| Role |
Name |
Disclosure |
Details |
| Author | William B Rizzo, MD, Professor, Department of Pediatrics, University of Nebraska Medical Center | Nothing to disclose | Details | | Medical Editor | Erawati V Bawle, MD, FAAP, FACMG, Director, Division of Genetic and Metabolic Disorders, Department of Pediatrics, Children's Hospital of Michigan; Professor (Clinician-Educator), Wayne State University School of Medicine | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | Managing Editor | Hagop Youssoufian, MD, MSc, Vice President of Clinical Research, ImClone Systems Incorporated | Nothing to disclose | Details | | CME Editor | Paul D Petry, DO, FACOP, FAAP, Consulting Staff, Freeman Pediatric Care, Freeman Health System | Nothing to disclose | Details | | Chief Editor | Bruce Buehler, MD, Professor, Department of Pediatrics, Pathology and Microbiology, Executive Director, Hattie B Munroe Center for Human Genetics and Rehabilitation, University of Nebraska Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Hagop Youssoufian, Managing Editor |
The contributor discloses no conflict of interest. |
|